In muscle biopsies from ALS patients, however, GFRα1 levels are maintained (Yamamoto et al., 1999), and GFRα1 is also expressed at similar levels in spinal cord samples of ALS patients and controls (Mitsuma et al., 1999). This evidence concerns the gene GFRA1 and amyotrophic lateral sclerosis.